Evaluation and Modeling with the Therapeutic Effects Group
Members
Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87
Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18
Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83
Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99
Doctorante
autre
Tel: 04 72 44 81 42
Praticien hospitalier
HCL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier émérite
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01
Post-doc
UCBL
Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20
Doctorante
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Post-doc
UCBL
Doctorante
UCBL
Tel: 04 72 44 81 42
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 211 to 240 publications on 613 in total
Role of ultrasonography in the assessment of correct endotracheal tube placement in neonates
Acta Paediatrica . 109 ( 5 ) : 1057-1059
DOI: 10.1111/apa.15097
Journal article
see the publicationEfficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis
CNS Spectrums . 26 ( 5 ) : 459-467
Journal article
see the publicationClinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
Journal of Cystic Fibrosis .
Journal article
see the publicationReal-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine . 201 ( 2 ) : 188-197
Journal article
see the publicationImpact of Coexistence Phenotype Between Staphylococcus aureus and Pseudomonas aeruginosa Isolates on Clinical Outcomes Among Cystic Fibrosis Patients
Frontiers in Cellular and Infection Microbiology . 10 : 105996
Journal article
see the publicationEarly trajectories of skin thickening are associated with severity and mortality in systemic sclerosis
Arthritis Research and Therapy . 22 ( 1 ) : 30
Journal article
see the publicationFrench recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
Orphanet Journal of Rare Diseases . 15 ( S2 ) : 351
Journal article
see the publicationEarly-onset autoimmunity associated with SOCS1 haploinsufficiency
Nature Communications . 11 ( 1 ) : 5341
Journal article
see the publicationAssessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study
BMJ Open . 10 ( 11 ) : e041268
Journal article
see the publicationInconclusive efficacy of intervention on upper-limb function after tetraplegia: A systematic review and meta-analysis
Annals of physical and rehabilitation medicine . 63 ( 3 ) : 230-240
Journal article
see the publicationContribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts
The Lancet Rheumatology . 2 ( 2 ) : e99-e109
Journal article
see the publicationPublication language and the estimate of treatment effects of physical therapy on balance and postural control after stroke in meta-analyses of randomised controlled trials
PLoS ONE . 15 ( 3 ) : e0229822
Journal article
see the publicationSyndrome de Klinefelter, rôle du chromosome Y dans l’espérance de vie humaine ?
36ème Congrès de la Société Française d'Endocrinologie (SFE Marseille 2020) . 81 ( 4 ) : 194
Conference paper
see the publicationCollaboration between academics, small pharmaceutical company and patient organizations in the development of a new formulation of cysteamine in nephropathic cystinosis: A successful story
Thérapie . 75 ( 2 ) : 169--173
Journal article
see the publicationMonogenic lupus: Dissecting heterogeneity
Autoimmunity Reviews . 18 ( 10 ) : 102361
Journal article
see the publicationDo patients with cystic fibrosis participating in clinical trials demonstrate placebo response? A meta-analysis
Journal of Cystic Fibrosis . 18 ( 4 ) : 461 - 467
Journal article
see the publicationOff-label drug prescriptions in French general practice: a cross-sectional study
BMJ Open . 9 ( 4 ) : e026076
Journal article
see the publicationA capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France
Thérapie . 74 : 645 - 650
Journal article
see the publicationThe French Pregnancy Cohort: Medication use during pregnancy in the French population
PLoS ONE . 14 ( 7 ) : e0219095
Journal article
see the publicationAdverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers
Joint Bone Spine . 86 ( 3 ) : 351-355
Journal article
see the publicationOff-label drug prescriptions in French general practice: a cross-sectional study
BMJ Open . 9 ( 4 ) : e026076
Journal article
see the publicationAssociation between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis
Diabetes Metab .
Journal article
see the publicationGLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
PLoS ONE . 14 ( 6 ) : e0217701
Journal article
see the publicationINN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice
European Journal of Clinical Pharmacology . 75 ( 2 ) : 275-283
Journal article
see the publicationPredictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients
Clinical Kidney Journal . 12 ( 3 ) : 365-372
DOI: 10.1093/ckj/sfy096
Journal article
see the publicationSafety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database
Joint Bone Spine . 86 ( 3 ) : 343-350
Journal article
see the publicationQuantitative Prediction of Interactions Mediated by Transporters and Cytochromes: Application to Organic Anion Transporting Polypeptides, Breast Cancer Resistance Protein and Cytochrome 2C8
Clinical Pharmacokinetics . 59 ( 6 ) : 757-770
Journal article
see the publication
You also, comment on this article